CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 8-K Event Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Medical Officer gave up 10,595 shares (to pay taxes)
- 8-K Event Other events
- 4 Conversion 10% owner acquired 960,000 shares (conversion)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy Director bought 20,000 shares at $1.24 ($24,800)
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 424B4 Offering Prospectus
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-K Event Material agreement · Other events
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 28 of 33 · 652 filings